EFPIA has published this week its 2024 Pipeline Review – Innovation for unmet need. The report highlights a range of factors contributing to a major shift in the types of diseases impacting society. These include an aging population, climate change, lifestyle choices and antimicrobial resistance (AMR).
It shows that across the pipeline innovative advances in prevention and treatment are emerging that promise to alleviate a significant part of this disease burden, addressing the needs of patients and significantly improving patient care.
The report estimates that around 20-30 million Europeans are suffering from a rare disease, while mental health conditions, including depression remain profound and multi-faceted. Patients living with these conditions need new treatments.
